These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20439528)

  • 41. Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment.
    Dall'Ara F; Lazzaroni MG; Antonioli CM; Airò P
    Rheumatol Int; 2017 May; 37(5):847-851. PubMed ID: 28160072
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Problems with Franco-American systemic sclerosis study.
    Anderson ST
    J Rheumatol; 2007 Aug; 34(8):1784-5; author reply 1785. PubMed ID: 17902207
    [No Abstract]   [Full Text] [Related]  

  • 43. Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression.
    Cavazzana I; Ceribelli A; Airo' P; Zingarelli S; Tincani A; Franceschini F
    Autoimmun Rev; 2009 Jun; 8(7):580-4. PubMed ID: 19393210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis.
    Yayla ME; İlgen U; Düzgün N
    Turk J Med Sci; 2018 Feb; 48(1):10-15. PubMed ID: 29479936
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies to fibrillarin, PM-Scl and RNA polymerase III detected by ELISA assays in patients with systemic sclerosis.
    Villalta D; Morozzi G; Tampoia M; Alpini C; Brusca I; Salgarolo V; Papisch W; Bizzaro N
    Clin Chim Acta; 2010 May; 411(9-10):710-3. PubMed ID: 20138166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
    Kuwana M; Kimura K; Kawakami Y
    Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis.
    Bunn CC; Denton CP; Shi-Wen X; Knight C; Black CM
    Br J Rheumatol; 1998 Jan; 37(1):15-20. PubMed ID: 9487245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
    Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis.
    Betteridge ZE; Woodhead F; Lu H; Shaddick G; Bunn CC; Denton CP; Abraham DJ; du Bois RM; Lewis M; Wells AU; McHugh NJ
    Arthritis Rheumatol; 2016 Nov; 68(11):2778-2783. PubMed ID: 27273608
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late onset systemic sclerosis with seronegativity: a rare presentation of an uncommon disease.
    Saxena D; Jain D; Yadav M; Giri K; Yadav T; Jain P
    Reumatismo; 2019 Oct; 71(3):166-170. PubMed ID: 31649382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications.
    Shah AA; Rosen A
    Curr Opin Rheumatol; 2011 Nov; 23(6):530-5. PubMed ID: 21825998
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis.
    Iniesta Arandia N; Simeón-Aznar CP; Guillén Del Castillo A; Colunga Argüelles D; Rubio-Rivas M; Trapiella Martínez L; García Hernández FJ; Sáez Comet L; Egurbide Arberas MV; Ortego-Centeno N; Freire M; Marí Alfonso B; Vargas Hitos JA; Ríos Blanco JJ; Todolí Parra JA; Rodríguez-Carballeira M; Marín Ballvé A; Chamorro Fernández AJ; Pla Salas X; Madroñero Vuelta AB; Ruiz Muñoz M; Fonollosa Pla V; Espinosa G;
    Clin Exp Rheumatol; 2017; 35 Suppl 106(4):98-105. PubMed ID: 28980912
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis.
    Bardoni A; Rossi P; Salvini R; Bobbio-Pallavicini F; Caporali R; Montecucco C
    Clin Exp Rheumatol; 2003; 21(3):301-6. PubMed ID: 12846047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
    Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
    J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer. Can cancer trigger autoimmunity?
    Teng MW; Smyth MJ
    Science; 2014 Jan; 343(6167):147-8. PubMed ID: 24408426
    [No Abstract]   [Full Text] [Related]  

  • 58. Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?
    Benyamine A; Bertin D; Heim X; Granel B; Bardin N
    Eur J Intern Med; 2017 Oct; 44():e42-e44. PubMed ID: 28781194
    [No Abstract]   [Full Text] [Related]  

  • 59. Autoantibody reactive with RNA polymerase III in systemic sclerosis.
    Okano Y; Steen VD; Medsger TA
    Ann Intern Med; 1993 Nov; 119(10):1005-13. PubMed ID: 8214977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A case of systemic sclerosis].
    Taieb D; Chauveau S; Khamis W; de Montmollin N; Sesé L; Duchemann B; Nunes H; Uzunhan Y
    Rev Mal Respir; 2020 Apr; 37(4):341-345. PubMed ID: 32284205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.